Factors Associated With Kidney Disease Progression and Mortality in a Referred CKD Population

被引:54
作者
Hoefield, Richard A. [1 ]
Kalra, Philip A. [1 ]
Baker, Patricia [2 ]
Lane, Beverley [1 ]
New, John P. [1 ]
O'Donoghue, Donal J. [1 ]
Foley, Robert N. [3 ,4 ]
Middleton, Rachel J. [1 ]
机构
[1] Univ Manchester, Salford Royal Hosp Fdn Trust, Vasc Res Grp, Manchester Acad Hlth Sci Ctr, Salford, Lancs, England
[2] Univ Manchester, NW Inst Biohlth Informat, Manchester, Lancs, England
[3] Chron Dis Res Grp, Minneapolis, MN USA
[4] Univ Minnesota, Minneapolis, MN USA
关键词
Chronic kidney disease (CKD); estimated glomerular filtration rate (eGFR); epidemiology; progression; mortality; RENAL-INSUFFICIENCY; CARDIOVASCULAR-DISEASE; RISK-FACTORS; DEATH; NEPHROPATHY; REPLACEMENT;
D O I
10.1053/j.ajkd.2010.06.010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Knowing how kidney disease progresses is important for decision making in patients with chronic kidney disease (CKD) and for designing clinical services. Study Design: Prospective cohort study. Setting & Participants: We examined renal function trajectories in CRISIS (Chronic Renal Insufficiency Standards Implementation Study), in which 1,325 patients with CKD stages 3-5 and mean age of 65.1 years were followed up prospectively for a median of 26 months after referral to a regional nephrology center in the United Kingdom. By protocol, estimated glomerular filtration rate was determined every 12 months. Predictors: CKD stage defined as estimated glomerular filtration rate > 45 (stage 3a), 30-44 (3b), 15-29 (4), and < 15 (5) mL/min/1.73 m(2). Outcomes: Onset of renal replacement therapy (RRT), death, the composite end point of RRT or death, or decreasing CKD stage. Results: During a median follow-up of 26 months, 13% reached the end point of RRT (5.1 events/100 patient-years), 20% died (9.6 deaths/100 patient-years), and 33% reached the combined end point of RRT or death (14.7 events/100 patient-years). For stage 3a, baseline prevalence and annual probabilities of decreasing CKD stage, RRT, and death were 18.0%, 0.41, 0.01, and 0.02, respectively. Corresponding values for stage 3b were 32.5%, 0.22, < 0.01, and 0.06; for stage 4, 36.5%, 0.17, 0.03, and 0.10; and for stage 5, 13.2%, zero (by definition), 0.31, and 0.08, respectively. Markov model projections suggested a steady decrease for proportions with stages 3a, 3b, and 4; a steady increase for death and RRT; and a biphasic pattern for (non-RRT) stage 5, with a plateau in the first 2 years followed by a steady decrease. Limitations: Single-center observational study. Conclusion: This study suggests that death and RRT are the dominant outcomes in patients referred for management of CKD and that most patients spend comparatively little time in late stages without RRT. Am J Kidney Dis 56: 1072-1081. (C) 2010 by the National Kidney Foundation, Inc.
引用
收藏
页码:1072 / 1081
页数:10
相关论文
共 32 条
[1]   Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].
Adler, AI ;
Stevens, RJ ;
Manley, SE ;
Bilous, RW ;
Cull, CA ;
Holman, RR .
KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232
[2]  
Agardh CD, 1996, J HUM HYPERTENS, V10, P185
[3]  
[Anonymous], 2002, American Journal of Kidney Disease, V39, pS46, DOI DOI 10.1053/AJKD.2002.30943
[4]   Evolving Trends in Clinical Presentation of and Renal Replacement Therapy for Chronic Kidney Disease [J].
Ansell, David ;
Tomson, Charles R. V. .
NEPHRON CLINICAL PRACTICE, 2009, 111 (04) :C265-C267
[5]   Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll [J].
Casiglia, E ;
Mazza, A ;
Tikhonoff, V ;
Pavei, A ;
Privato, G ;
Schenal, N ;
Pessina, AC .
JOURNAL OF HUMAN HYPERTENSION, 2002, 16 (01) :21-31
[6]   Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan [J].
Chiu, Yen-Ling ;
Chien, Kuo-Liong ;
Lin, Shuei-Liong ;
Chen, Yung-Ming ;
Tsai, Tun-Jun ;
Wu, Kwan-Dun .
NEPHRON CLINICAL PRACTICE, 2008, 109 (03) :C109-C118
[7]   Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: The data of the meta-analyses [J].
Chiurchiu, C ;
Remuzzi, G ;
Ruggenenti, P .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 :S58-S63
[8]   Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition [J].
Chuahirun, T ;
Wesson, DE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :376-382
[9]   Chronic kidney disease and cardiovascular disease in the Medicare population [J].
Collins, AJ ;
Li, SL ;
Gilbertson, DT ;
Liu, JN ;
Chen, SC ;
Herzog, CA .
KIDNEY INTERNATIONAL, 2003, 64 :S24-S31
[10]  
EMBERSON J, 2008, BRIT REN SOC REN ASS